Colby Howard

Published on October 3, 2025


Featured Article

ABT: CEO Ford’s Commercial Skill May Not Overcome Forecasting Misses and Margin Risk

Last Updated: October 3, 2025

Analyzing Management

Leadership in public companies plays a crucial role for hedge funds and asset managers during both initial due diligence and continuous risk assessment. ManagementTrack offers a consistent approach that eliminates distractions, highlighting distinct strengths and weaknesses, identifying potential risks and opportunities, and drawing a straight line between CEO actions and investment outcomes.

CEO Ford’s commercial skill may not overcome forecasting misses and margin risk.

Analysis of Abbott Laboratories CEO Robert Ford

Despite proven commercial execution and unique product expertise, recent forecasting failures may challenge Robert Ford’s ability to navigate near-term headwinds and achieve margin targets.

Management evaluated Robert Ford’s track record and skillset against the following key factors for ABT:

  • Expanding the TAVR sales force to accelerate U.S. market share.
  • Executing the Libre dual-analyte sensor launch to drive growth.
  • Offsetting $700M in headwinds to stabilize the Diagnostics division.
  • Offsetting headwinds to achieve 2025 margin expansion targets.

Robert Ford’s Track Record & Key Open Questions to Research

ManagementTrack provides track record analysis, career playbooks, strengths, and weaknesses for every CEO. It allows investors to dig deeper to uncover hard to find data to answer the most pressing questions.

Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ for more information.

Question #1
Given the need to achieve margin expansion through operational discipline, will Ford’s focus on visionary growth initiatives like Libre overshadow the rigorous oversight required to prevent another systemic failure like the infant formula crisis?

Question #2
When pursuing future M&A, will Ford’s playbook be defined by the disciplined integration of St. Jude, or does the CSI clinical trial failure reveal a tendency to prioritize a compelling strategic narrative over rigorous technical due diligence?

Question #3
Is the leader who drove Libre’s success with a big-picture commercial vision the same leader who can apply the granular, operational discipline needed to fix the forecasting failures and stabilize the Diagnostics division?

Why Do Investors Use ManagementTrack?

How does ManagementTrack assess Robert Ford at ABT?
Through its proprietary career analysis and interviews with former colleagues, ManagementTrack establishes an executive’s track record, key strengths, and weaknesses. This profile is then benchmarked against the most critical challenges and opportunities facing the company. For ABT, these key factors are expanding the TAVR sales force, launching the next-generation Libre sensor, stabilizing the Diagnostics division, and achieving 2025 margin targets despite significant headwinds.

What additional methodologies does ManagementTrack utilize to forecast company performance based on its executive team?
ManagementTrack utilizes proprietary models to identify atypical executive evasion during earnings call Q&A. It also scrutinizes all insider transactions for outlier trades that can predict future stock movements. When combined with the ManagementTrack Rating, a predictive 1-10 score for every executive, these tools offer investors a clear, forward-looking view on how leadership will likely impact company performance.

What is the scope of ManagementTrack’s executive coverage?
ManagementTrack offers continuous, real-time coverage of the executive suites at all public companies.

How to Learn More

Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ to see our deep dive analysis on any executive.

 

Author

Author Colby Howard is the co-founder and President of Paragon Intel. Paragon Intel’s ManagementTrack is the premier executive analysis platform for hedge funds, asset managers, corporations, boards, and recruiters. Our proprietary data, built over a decade of analysis, allows us to analyze each public company executive to understand their fit and ability to execute at their company. We leverage our proprietary data – key quantitative research on an executive’s career plus interviews with their former colleagues – with public documents, including SEC filings (10-K, 10-Q), investor presentations, press releases, and earnings call transcripts. to build a holistic, evidence-based view of an executive’s capabilities and playbook.

Sources

  • Verified Career History by ManagementTrack for Robert Ford
  • Analysis of Capital Allocation, Performance, and Fundamentals across career by ManagementTrack
  • Abbott Laboratories 10Q
  • Abbott Laboratories 10K
  • Abbott Laboratories Earnings Calls
  • Abbott Laboratories Press Releases

 

Relevant Links

© 2023 Paragon Intel